UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049934
Receipt number R000056872
Scientific Title A multicenter intervention study on the effectiveness of group psychoeducation using depression guidelines for patients to prevent relapse
Date of disclosure of the study information 2022/12/28
Last modified on 2024/01/02 19:13:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter intervention study on the effectiveness of group psychoeducation using depression guidelines for patients to prevent relapse

Acronym

Group psychoeducation study with depression guidelines for patients

Scientific Title

A multicenter intervention study on the effectiveness of group psychoeducation using depression guidelines for patients to prevent relapse

Scientific Title:Acronym

Group psychoeducation study with depression guidelines for patients

Region

Japan


Condition

Condition

Major Depressive Disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to conduct group psychoeducation for patients with depression using the "Easy-to-understand Depression Treatment Guide for Patients and Families" and to examine its impact on patients' understanding of the disease and their quality of life and well-being in the mid- to long-term, which are necessary for preventing relapse.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Patients' understanding of the disease, including prevention of relapse of depression

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Group Psychoeducation

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients whose attending physician determines that the current episode meets the criteria for major depressive disorder in the DSM-5
Patients who are judged by the attending physician to be in the recovery or maintenance phase of the current episode
Patients whose primary antidepressant has not been changed (dose reduction is allowed) nor whose primary psychotherapy has not been changed in the past 3 months

Key exclusion criteria

Patients with bipolar disorder
Patients with dementia
Patients with psychotic symptoms
Patients with alcohol or drug dependence
Patients with serious physical illnesses
Patients who are deemed unsuitable by the principal investigator or research coordinator

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Tsuboi

Organization

Kyorin University School of Medicine

Division name

Department of Neuropsychiatry

Zip code

181-8611

Address

6-20-2, Shinkawa, Mitaka-shi, Tokyo

TEL

0422-47-5511

Email

takashi.tsuboi.0821@gmail.com


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Tsuboi

Organization

Kyorin University School of Medicine

Division name

Department of Neuropsychiatry

Zip code

181-8611

Address

6-20-2, Shinkawa, Mitaka-shi, Tokyo

TEL

0422-47-5511

Homepage URL


Email

takashi.tsuboi.0821@gmail.com


Sponsor or person

Institute

Kyorin University

Institute

Department

Personal name



Funding Source

Organization

AMED

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Review Board of Osaka University Hospital

Address

2-2, Yamadaoka, Suita-shi, Osaka

Tel

06-6210-8296

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 12 Month 19 Day

Date of IRB

2023 Year 01 Month 04 Day

Anticipated trial start date

2023 Year 03 Month 01 Day

Last follow-up date

2028 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 12 Month 28 Day

Last modified on

2024 Year 01 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056872


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name